A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Trial details
- Registry ID
- NCT06767683
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic HypersomniaNCT06767683 | Alkermes, Inc. | Phase 2, Phase 3 | Recruiting | 2030-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |